Merle Ferguson

CIK: 0001749860

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BFNH

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Apr 22, 2026
Sale(S)
Direct
26.7M shares at avg. $0.01$401K
BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Apr 20, 2026
Gift(G)
Direct
20.6M shares at avg. $0.01$144K
BFNH
BIOFORCE NANOSCIENCES HOLDINGS, INC.
Apr 20, 2026
Gift(G)
Direct
4.1M shares at avg. $0.00$4K

		Type	Shares	Price		Ownership
Apr 22, 2026	BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.	Sale(S)	26,700,000	$0.01	$400,500	Direct
Apr 20, 2026	BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.	Gift(G)	20,580,000	$0.01	$144,060	Direct
Apr 20, 2026	BFNH BIOFORCE NANOSCIENCES HOLDINGS, INC.	Gift(G)	4,132,000	$0.00	$4,132	Direct

1-3 of 3 transactions

About Ferguson Merle

Ferguson Merle (SEC CIK 0001749860) files insider reports with the SEC as Director of BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH).

Signal8 holds 1 ownership filing by Ferguson Merle, a Form 4, filed on Sep 2, 2026. Those filings report 3 transactions, from Apr 20, 2026 to Apr 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Ferguson Merle's filings is in ENCINITAS, CA.

Recent filings by Ferguson Merle

Apr 22, 2026: Open-market sale of BFNH shares (Form 4, code S).
Apr 20, 2026: Gifts of BFNH shares (2 lines, Form 4, code G).

Other insiders filing for BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH)

Nexus Capital Investments, Inc., 10% Owner
Mager Scott, Director
KAISER RICHARD KAISER, CEO & CFO

How to read Form 4 transaction codes